和益 1709 - 股息配發率

現金殖利率: 3.09%、總殖利率: 3.09%、5年平均現金配發率: 90.61%
要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)

	EPS YoY		現金股利 YoY		股票股利 YoY	現金配發率 YoY		股票配發率 YoY	全部配發率 YoY
2023 (10)	0.88	-61.23	0.60	-66.67	0.00	68.18	-14.02	0.00	68.18	-14.02
2022 (9)	2.27	14.65	1.80	5.88	0.00	79.30	-7.64	0.00	79.30	-7.64
2021 (8)	1.98	70.69	1.70	41.67	0.00	85.86	-17.0	0.00	85.86	-17.0
2020 (7)	1.16	169.77	1.20	140.0	0.00	103.45	-11.03	0.00	103.45	-11.03
2019 (6)	0.43	-43.42	0.50	0.0	0.00	116.28	76.74	0.00	116.28	76.74
2018 (5)	0.76	-39.68	0.50	-66.67	0.00	65.79	-44.74	0.00	65.79	-44.74
2017 (4)	1.26	-28.81	1.50	-0.66	0.00	119.05	39.55	0.00	119.05	11.49
2016 (3)	1.77	33.08	1.51	27.97	0.38	85.31	-3.84	21.47	106.78	20.35

每股盈餘-近20季

	EPS QoQ YoY			本業EPS QoQ YoY			累計EPS QoQ YoY
23Q4 (20)	0.09	-72.73	-70.0	0.19	-13.64	-5.0	0.88	11.39	-61.23
23Q3 (19)	0.33	26.92	-38.89	0.22	83.33	-18.52	0.79	71.74	-59.9
23Q2 (18)	0.26	30.0	-65.33	0.12	-45.45	-80.33	0.46	130.0	-67.83
23Q1 (17)	0.20	-33.33	-70.59	0.22	10.0	-58.49	0.20	-91.19	-70.59
22Q4 (16)	0.30	-44.44	7.14	0.20	-25.93	-75.61	2.27	15.23	14.07
22Q3 (15)	0.54	-28.0	-8.47	0.27	-55.74	-48.08	1.97	37.76	15.2
22Q2 (14)	0.75	10.29	27.12	0.61	15.09	5.17	1.43	110.29	27.68
22Q1 (13)	0.68	142.86	28.3	0.53	-35.37	6.0	0.68	-65.83	28.3
21Q4 (12)	0.28	-52.54	-9.68	0.82	57.69	134.29	1.99	16.37	71.55
21Q3 (11)	0.59	0.0	55.26	0.52	-10.34	44.44	1.71	52.68	101.18
21Q2 (10)	0.59	11.32	118.52	0.58	16.0	114.81	1.12	111.32	138.3
21Q1 (9)	0.53	70.97	165.0	0.50	42.86	194.12	0.53	-54.31	165.0
20Q4 (8)	0.31	-18.42	287.5	0.35	-2.78	337.5	1.16	36.47	163.64
20Q3 (7)	0.38	40.74	245.45	0.36	33.33	200.0	0.85	80.85	136.11
20Q2 (6)	0.27	35.0	145.45	0.27	58.82	145.45	0.47	135.0	88.0
20Q1 (5)	0.20	150.0	42.86	0.17	112.5	6.25	0.20	-54.55	42.86
19Q4 (4)	0.08	-27.27	0.0	0.08	-33.33	0.0	0.44	22.22	0.0
19Q3 (3)	0.11	0.0	0.0	0.12	9.09	0.0	0.36	44.0	0.0
19Q2 (2)	0.11	-21.43	0.0	0.11	-31.25	0.0	0.25	78.57	0.0
19Q1 (1)	0.14	0.0	0.0	0.16	0.0	0.0	0.14	0.0	0.0

年/月	營收	月增率(%)	去年同期年增率(%)	累計營收	累計營收年增率(%)	近三月累計營收	存貨銷售比	備註(年增率變動50%需說明原因)
2024/3	9.12	9.85	-11.5	25.46	3.28	25.46	N/A	-
2024/2	8.3	3.09	19.24	16.35	13.89	24.56	N/A	-
2024/1	8.05	-2.03	8.86	8.05	8.86	23.68	N/A	-
2023/12	8.22	10.72	30.17	94.34	-10.76	22.31	1.41	-
2023/11	7.42	11.1	-2.05	86.12	-13.36	22.56	1.4	-
2023/10	6.68	-21.05	-39.21	78.7	-14.29	23.67	1.33	-
2023/9	8.46	-0.88	9.08	72.02	-10.91	23.31	1.32	-
2023/8	8.54	35.14	-2.39	63.56	-13.03	22.38	1.37	-
2023/7	6.32	-16.12	-27.28	55.03	-14.48	20.39	1.5	-
2023/6	7.53	14.98	-4.39	48.71	-12.48	24.06	1.35	-
2023/5	6.55	-34.39	-39.55	41.18	-13.81	26.83	1.21	-
2023/4	9.98	-3.09	28.82	34.63	-6.27	27.24	1.19	-
2023/3	10.3	48.01	-0.58	24.65	-15.58	24.65	1.44	-
2023/2	6.96	-5.87	-10.44	14.35	-23.83	20.66	1.72	-
2023/1	7.39	17.14	-33.22	7.39	-33.22	21.28	1.67	-
2022/12	6.31	-16.69	-5.52	105.72	14.91	24.87	1.56	-
2022/11	7.58	-31.05	-2.73	99.41	16.52	26.32	1.48	-
2022/10	10.99	41.67	50.19	91.83	18.45	27.49	1.41	十二烷苯系列產品，海外銷售量大幅增加
2022/9	7.76	-11.31	-4.69	80.84	15.14	25.19	1.55	-
2022/8	8.74	0.68	11.38	73.09	17.74	25.31	1.55	-
2022/7	8.69	10.28	40.1	64.34	18.67	27.39	1.43	-
2022/6	7.88	-27.3	-3.08	55.66	15.9	26.46	1.46	-
2022/5	10.83	39.82	20.45	47.78	19.77	28.94	1.34	-
2022/4	7.75	-25.21	2.73	36.95	19.41	25.88	1.5	-
2022/3	10.36	33.33	17.1	29.2	24.78	29.2	1.07	-
2022/2	7.77	-29.81	21.0	18.84	29.45	25.52	1.22	-
2022/1	11.07	65.74	36.12	11.07	36.12	25.54	1.22	-
2021/12	6.68	-14.23	0.9	91.99	8.54	21.78	1.45	-
2021/11	7.79	6.46	9.59	85.31	9.18	23.24	1.36	-
2021/10	7.32	-10.09	22.05	77.53	9.03	23.3	1.36	-
2021/9	8.14	3.64	-1.31	70.21	7.83	22.19	1.31	-
2021/8	7.85	26.64	27.08	62.07	9.15	22.18	1.31	-
2021/7	6.2	-23.71	-8.51	54.22	6.97	23.32	1.25	-
2021/6	8.13	-9.64	0.66	48.02	9.36	24.66	1.05	-
2021/5	8.99	19.26	59.03	39.9	11.32	25.38	1.02	主係產品銷售量增加及銷售價格調漲
2021/4	7.54	-14.75	14.15	30.94	2.51	22.81	1.14	-
2021/3	8.85	37.76	16.3	23.4	-0.74	23.4	1.02	-
2021/2	6.42	-21.04	-22.23	14.56	-8.86	21.18	1.13	-
2021/1	8.13	22.87	5.45	8.13	5.45	21.86	1.09	-
2020/12	6.62	-6.85	-19.9	84.76	-3.65	19.72	1.15	-
2020/11	7.11	18.56	22.17	78.14	-1.97	21.35	1.06	-
2020/10	5.99	-27.3	-30.36	71.1	-3.77	20.42	1.11	-
2020/9	8.25	33.46	24.34	65.11	-0.26	21.2	1.29	-
2020/8	6.18	-8.83	-21.79	56.87	-3.04	21.03	1.3	-
2020/7	6.78	-16.05	-24.53	50.69	-0.13	20.5	1.34	-
2020/6	8.07	42.74	30.36	43.91	5.11	20.33	1.31	-
2020/5	5.66	-14.39	-29.56	35.84	0.72	19.87	1.34	-
2020/4	6.61	-13.15	-11.78	30.18	9.54	22.47	1.19	-
2020/3	7.61	-7.88	-3.47	23.58	17.5	23.58	1.18	-
2020/2	8.26	7.05	38.18	15.97	31.07	24.24	1.15	-
2020/1	7.71	-6.67	24.23	7.71	24.23	21.79	1.28	-
2019/12	8.26	42.07	44.28	87.97	-10.07	22.69	1.36	-
2019/11	5.82	-32.42	-15.89	79.71	-13.45	21.06	1.47	-
2019/10	8.61	29.81	1.27	73.89	-13.25	23.14	1.34	-
2019/9	6.63	-16.06	-20.67	65.28	-14.86	23.51	1.36	-
2019/8	7.9	-12.01	0.78	58.65	-14.15	23.07	1.39	-
2019/7	8.98	44.99	13.78	50.75	-16.09	23.2	1.38	-
2019/6	6.19	-22.87	-37.21	41.77	-20.57	21.71	1.61	-
2019/5	8.03	7.21	-21.43	35.58	-16.73	0.0	N/A	-
2019/4	7.49	-4.96	-6.52	27.55	-15.25	0.0	N/A	-